|
(P1018) |
Die redox-aktivierte Proteinkinase A hemmt den Einwärtsgleichrichter-Kaliumkanal im Herzen |
| |
|
M. Trum, E. Zitron, P. Eaton, L. S. Maier, S. Wagner (Regensburg, Heidelberg; London, UK) |
|
(P1019) |
Insulin Facilitates Aldosterone-induced Electrical Remodeling via SGK and CaMKII in the Heart: Implications for Type 2 Diabetes treatment? |
| |
|
E. Rudakova, M. Röhlig, C. Wacker, A. El-Armouche, T. Volk, M. Wagner (Erlangen, Dresden) |
|
(P1020) |
Intracellular Na+ is increased in atrial myocytes from patients with atrial fibrillation |
| |
|
K. Hammer, A. Maier, H. Winkelmann, S. Wagner, L. S. Maier (Regensburg; Manhattan, KS, US) |
|
(P1021) |
Antiarrhythmic drugs target atrial TASK-1 K+ channels: mode of action and implications for AF therapy |
| |
|
C. Schmidt, F. Wiedmann, A. Ratte, X. Zhou, S. Lang, W. Wenzel, M. Karck, M. Borggrefe, G. Seebohm, H. A. Katus, D. Thomas (Heidelberg, Mannheim, Karlsruhe, Münster) |
|
(P1022) |
A new computational model for the SERCA2a-regulation by phospholamban and sarcolipin in human atrial cardiomyocytes |
| |
|
P. Erfanian Abdoust, J. Heijman, D. Dobrev (Essen; Maastricht, NL) |
|
(P1023) |
Hyperpolarization of the atrial resting membrane potential in heterozygous Na+/Ca2+-exchanger knockout mice |
| |
|
N. Bögeholz, P. Pauls, J. S. Schulte, G. Frommeyer, D. Dechering, U. Kirchhefer, F. U. Müller, L. Eckardt, C. Pott (Münster) |